The SCOPE Scientific Symposium (SSS)

Tuesday: February 18, 2020 from 2:00 to 5:00 pm at CHI’s SCOPE Summit in Orlando

The new SSS provides a forum where academics, sponsors, CROs, and other parties who share a common interest in the conduct of clinical trials can showcase their research to improve a process that in many ways is outdated and in dire need for efficiencies.  The symposium will bring data-driven, scientific practices to clinical research design and execution.  These improvements should result in better decisions in new drug evaluations; providing patients with broader and more rapid access to novel medications.  Some of the highlights include:

  • Speaking: A request for abstract submissions where researchers will provide the background, methods, results, and conclusions of their work
  • Review: An independent body of scientific peer review will be formed to score the abstracts
  • Awards: Awards and levels of presentation will be assigned based on the scores as well as the greatest potential impact to the SCOPE attendees
  • The deadline for submissions is October 30, 2019. Please use the online submission formThe SCOPE Scientific Symposium:
  • Attending: There is no added cost to attend this event at SCOPE, but Attendees and Speakers must be registered as a “Best Value” SCOPE conference participant (using discount code SSS). If you would like to attend, please save your seat by registering with Melissa Dolen at or (+1) 781-972-5418 or online at

SUBMIT YOUR SCOPE Scientifics Symposium (SSS) PROPOSAL!!!


Program Committee

Kyle Holen, MD, Head, Development Design Center, Research & Development, AbbVie  
Michelle Crouthamel, PhD, Director, Digital Health & Innovation, AbbVie
Mary Jo Lamberti, PhD, Associate Director and Research Assistant Professor, Tufts Center for the Study of Drug Development (CSDD)
Craig Lipset, MBA, Former Head, Clinical Innovation, Pfizer; Venture Partner, Boston Millennia Partners (BMP) & FundRx; Advisor, People-Centered Research Foundation (PCRF)
Micah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)
Marina Filshtinsky, MD, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)


Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy and Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Resource Management, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence, Post-Marketing Studies, Observational Research, Accessing and Generating RWD, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, Clinical Biomarkers and Biospecimens, and Central Lab Solutions, and an all new track on Medical Device Clinical Trial Operations and Regulations.

SUBMIT YOUR SCOPE Scientifics Symposium (SSS) PROPOSAL!!!

Key Contacts

For more details on the conference, please contact:

Micah Lieberman

Executive Director, Conferences
Cambridge Healthtech Institute (CHI)
T: (+1) 541. 482.4709

For partnering and sponsorship information, please contact:
Companies A-K

Ilana Quigley

Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5457

For partnering and sponsorship information, please contact:
Companies L-Z

Patty Rose

Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.1349

Group Discounts are Available

For information contact:

Melissa Dolen

T: (+1) 781.972.5418

SCOPE 2019 attracted record attendance with more than 2,000 participants

A Leader in the Clinical Trial Industry: SCOPE Grows by 20% for the fourth consecutive year

2019 Event Featured

  • 2,000+ participants
  • 19 conferences
  • Participant Engagement Awards
  • Dedicated Exhibit Hall Hours & Networking Functions
  • Interactive Breakout Discussions
  • Greater Gift Vaccine Dontations

The impressive executive audience at SCOPE came together for invaluable networking opportunities with more than 52% of the attendees titled as a decision maker from leading Pharma (20%), CRO (35%), and Biotech companies (20%). Industry leaders and key decision makers representing 28 different countries and more than 700 unique organizations shared case studies, collaborated on best practices and provided unique perspectives on poignant issues that the field currently faces.

2019 Attendee Demographics